ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01941836
Recruitment Status : Completed
First Posted : September 13, 2013
Last Update Posted : September 11, 2015
Sponsor:
Collaborator:
Medpace, Inc.
Information provided by (Responsible Party):
Esperion Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2014
  Actual Study Completion Date : November 2014
  Certification/Extension First Submitted : August 13, 2015
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):